Steven W. Muchmore

5.8k citations

49 papers · 4.6k indexed · 2 hit papers · h-index 26

Molecular Biology top 2%
- Protein Structure and Dynamics 10
- Biochemical and Molecular Research 3
Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods 11
Immunology top 5%
Toxicology top 5%
Pharmacology top 5%
Materials Chemistry
- Enzyme Structure and Function 7
- Crystallization and Solubility Studies 3
Spectroscopy
- Analytical Chemistry and Chromatography 3
Infectious Diseases
- HIV/AIDS drug development and treatment 3
Organic Chemistry
- Click Chemistry and Applications 3

Co-authors: Scott P. Brown Stephen W. Fesik Craig B. Thompson Heng Liang John E. Harlan Shi‐Chung Ng Robert Meadows Michael Sattler
Cited by: Molecular Biology Computational Theory and Mathematics Immunology
Journals: Nature (2 papers)Science (1 paper)Journal of Biological Chemistry (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Steven W. Muchmore

49 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Steven W. Muchmore

Since Specialization

Citations

This map shows the geographic impact of Steven W. Muchmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven W. Muchmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven W. Muchmore more than expected).

Fields of papers citing papers by Steven W. Muchmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven W. Muchmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven W. Muchmore. The network helps show where Steven W. Muchmore may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven W. Muchmore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven W. Muchmore Line = papers co-authored together Steven W. Muchmore links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	POSIT: Flexible Shape-Guided Docking For Pose Prediction Journal of Chemical Information and Modeling ·Brian Kelley,Scott P. Brown,Gregory L. Warren,Steven W. Muchmore	2015	108
2	ALOHA: a novel probability fusion approach for scoring multi-parameter drug-likeness during the lead optimization stage of drug discovery Journal of Computer-Aided Molecular Design ·Derek A. Debe,Ravindra B. Mamidipaka,Robert J. Gregg,James T. Metz,Rishi R. Gupta,Steven W. Muchmore	2013	7
3	Frozen out: molecular modeling in the age of cryocrystallography Journal of Computer-Aided Molecular Design ·Yvonne C. Martin,Steven W. Muchmore	2011	2
4	Molecular Shape and Medicinal Chemistry: A Perspective Journal of Medicinal Chemistry ·Anthony Nicholls,Georgia B. McGaughey,Robert P. Sheridan,Andrew C. Good,Gregory L. Warren,Magali Mathieu,Steven W. Muchmore,Scott P. Brown,Jennifer Grant,James A. Haigh,Neysa Nevins,Ajay N. Jain,Brian Kelley	2010	254
5	Healthy skepticism: assessing realistic model performance Drug Discovery Today ·Scott P. Brown,Steven W. Muchmore,Philip J. Hajduk	2009	97
6	Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping Journal of Chemical Information and Modeling ·Steven W. Muchmore,Derek A. Debe,James T. Metz,Scott P. Brown,Yvonne C. Martin,Philip J. Hajduk	2008	121
7	4-Amino-5-aryl-6-arylethynylpyrimidines: Structure–activity relationships of non-nucleoside adenosine kinase inhibitors Bioorganic & Medicinal Chemistry ·Mark A. Matulenko,Ernest S. Paight,Robin R. Frey,Arthur Gomtsyan,Stanley DiDomenico,Meiqun Jiang,Chih‐Hung Lee,Andrew O. Stewart,Haixia Yu,Kathy L. Kohlhaas,Karen M. Alexander,Steve McGaraughty,Joseph P. Mikusa,Kennan C. Marsh,Steven W. Muchmore,Clarissa L. Jakob,Elizabeth A. Kowaluk,Michael F. Jarvis,Shripad S. Bhagwat	2006	25
8	Crystal Structures of Human Adenosine Kinase Inhibitor Complexes Reveal Two Distinct Binding Modes Journal of Medicinal Chemistry ·Steven W. Muchmore,Richard A. Smith,Andrew O. Stewart,Marlon Cowart,Arthur Gomtsyan,Mark A. Matulenko,Haixia Yu,Jean M. Severin,Shripad S. Bhagwat,Chih‐Hung Lee,Elizabeth A. Kowaluk,Michael F. Jarvis,Clarissa L. Jakob	2006	23
9	The Use of Three‐Dimensional Shape and Electrostatic Similarity Searching in the Identification of a Melanin‐Concentrating Hormone Receptor 1 Antagonist Chemical Biology & Drug Design ·Steven W. Muchmore,Andrew J. Souers,Irini Akritopoulou‐Zanze	2006	62
10	Design, synthesis, and activity of 4-quinolone and pyridone compounds as nonthiol-containing farnesyltransferase inhibitors Bioorganic & Medicinal Chemistry Letters ·Qun Li,Akiyo Claiborne,Tongmei Li,Lisa Hasvold,Vincent S. Stoll,Steven W. Muchmore,Clarissa G. Jakob,Wendy Gu,Jerry D. Cohen,Charles W. Hutchins,David J. Frost,Saul H. Rosenberg,Hing L. Sham	2004	21
11	The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain Journal of Biological Chemistry ·Björn Kauppi,Clarissa G. Jakob,Mathias Färnegårdh,Jie Yang,Harri Ahola,M. Alarcon,K. Calles,Owe Engström,John E. Harlan,Steven W. Muchmore,Anna-Karin Ramqvist,S. Thorell,Lars Öhman,Jonathan Greer,Jan-Åke Gustafsson,Jan Carlstedt‐Duke,Mats Carlquist	2003	277
12	Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin,Alan S. Florjancic,Jerome Cohen,Wen‐Zhen Gu,David J. Frost,Steven W. Muchmore,Hing L. Sham	2003	12
13	Automated Crystal Mounting and Data Collection for Protein Crystallography Structure ·Steven W. Muchmore,Jeffrey L. Olson,Ronald N. Jones,Jeff Pan,Michael L. Blum,Jonathan Greer,S.M. Merrick,Peter Magdalinos,V. Nienaber	2000	54
14	Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein Survivin Molecular Cell ·Steven W. Muchmore,Jun Chen,Clarissa G. Jakob,Dorothy Zakula,Edmund D. Matayoshi,Wei Wu,Haichao Zhang,Fengzhi Li,Shi‐Chung Ng,Dario C. Altieri	2000	104
15	Experiences with CCD detectors on a home X-ray source Acta Crystallographica Section D Biological Crystallography ·Steven W. Muchmore	1999	9
16	Structure of Secreted Aspartic Proteinases from Candida Advances in experimental medicine and biology ·Cele Abad‐Zapatero,Robert C. Goldman,Steven W. Muchmore,Charles W. Hutchins,Tetsuro Oie,Kent D. Stewart,Sue Cutfield,J.F. Cutfield,Stephen I. Foundling,Thomas L. Ray	1998	13
17	Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents Protein Science ·Cele Abad‐Zapatero,Robert C. Goldman,Steven W. Muchmore,Charles W. Hutchins,Kent D. Stewart,Jorge Navaza,Candia D. Payne,Thomas L. Ray	1996	92
18	Crystallization of the NAD-dependent malic enzyme from the parasitic nematode Ascaris suum Journal of Molecular Biology ·Luke Clancy,G S Rao,B.C. Finzel,Steven W. Muchmore,Debra R. Holland,Keith David Watenpaugh,Harini Krishnamurthy,Robert M. Sweet,Paul Cook,Ben G. Harris,(unknown)	1992	10
19	Crystal structure of recombinant human interleukin-1β at 2·0 Å resolution Journal of Molecular Biology ·B.C. Finzel,L.L. Clancy,Debra R. Holland,Steven W. Muchmore,Keith David Watenpaugh,Howard Einspahr	1989	158
20	Crystallization of purified recombinant human interleukin‐1β Proteins Structure Function and Bioinformatics ·D. B. Carter,Kimberly A. Curry,C‐S. C. Tomich,Anthony W. Yem,Martin R. Deibel,Daniel E. Tracey,J W Paslay,J. B. Carter,Nicole Y. Thériault,Peter K.W. Harris,Ilene M. Reardon,Heidi A. Zürcher-Neely,Robert L. Heinrikson,L.L. Clancy,Steven W. Muchmore,Keith David Watenpaugh,Howard Einspahr	1988	41

About Steven W. Muchmore

Steven W. Muchmore is a scholar working on Computational Theory and Mathematics, Molecular Biology and Spectroscopy, having authored 49 papers that have together received 4.6k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (11 papers), Protein Structure and Dynamics (10 papers), Enzyme Structure and Function (7 papers), Analytical Chemistry and Chromatography (3 papers), Biochemical and Molecular Research (3 papers), Crystallization and Solubility Studies (3 papers), HIV/AIDS drug development and treatment (3 papers) and Click Chemistry and Applications (3 papers). The work is most often cited by research in Molecular Biology (3.3k citations), Computational Theory and Mathematics (761 citations) and Immunology (514 citations). Steven W. Muchmore has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Scott P. Brown, Stephen W. Fesik, Craig B. Thompson, Heng Liang, John E. Harlan, Shi‐Chung Ng, Robert Meadows, Michael Sattler, David G. Nettesheim and Brian S. Chang. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact